Small biotech CEO ex­o­dus con­tin­ues as vTv, a trou­bled for­mer Alzheimer's play­er, sees chief leave af­ter just 4 months

It’s been a bad cou­ple months for the heads of small, strug­gling biotechs.

On Fri­day, vTv ther­a­peu­tics, a North Car­oli­na com­pa­ny that once raised a $117 mil­lion IPO on the promise that it could res­ur­rect an old Pfiz­er drug for Alzheimer’s, an­nounced that CEO Deepa Prasad had re­signed. Prasad had on­ly been CEO since Oc­to­ber, and no rea­son was giv­en for the de­par­ture.

The long­time health­care ex­ec­u­tive joins a small ex­o­dus of biotech chiefs, as a his­toric bear mar­ket puts in­creased pres­sure on com­pa­nies strapped for cash and starved for in­vestor con­fi­dence.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER